Cutler Group LP Repare Therapeutics Inc. Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Cutler Group LP holds 1,000 shares of RPTX stock, worth $3,280. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$3,280% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding RPTX
# of Institutions
62Shares Held
35.4MCall Options Held
50KPut Options Held
300-
Bvf Inc San Francisco, CA10.3MShares$33.9 Million1.13% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.37MShares$11.1 Million3.82% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$10.9 Million0.27% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$9.73 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$8.68 Million23.86% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $138M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...